MOGAD: How It Differs From and Resembles Other Neuroinflammatory Disorders
- PMID: 32755221
- DOI: 10.2214/AJR.20.24061
MOGAD: How It Differs From and Resembles Other Neuroinflammatory Disorders
Abstract
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a distinct CNS inflammatory disease with symptoms and imaging findings that overlap other neuroinflammatory disorders. We highlight the imaging characteristics of MOGAD and contrast them with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). Intracranial features that suggest MOGAD include childhood acute disseminated encephalomyelitis pattern with diffuse signal abnormality in the cortical gray matter, subcortical white matter, deep white matter, and deep gray matter on T2-weighted and FLAIR images; few bilateral T2-hyperintense fluffy and poorly demarcated lesions; pontine or thalamic involvement (or both); and cerebellar peduncle lesions in children. Intraorbitally, one sees edematous, enlarged, tortuous optic nerve or nerves; bilateral long-segment T2 hyperintensity of anterior segments of the optic nerve; sparing of the optic chiasm and retrochiasmatic pathways; and perioptic nerve sheath and surrounding orbital fat enhancement. Spinal involvement is seen as longitudinally extensive transverse myelitis with a sagittal T2-hyperintense intramedullary spinal line, the axial "H" spinal cord sign (central cord gray matter T2 hyperintensity), and conus medullaris involvement. Early accurate diagnosis of MOGAD is important because prognosis and treatment differ from those for NMOSD and MS.
Keywords: MOGAD; MRI; brain; multiple sclerosis; myelin oligodendrocyte glycoprotein antibody–associated disease; neuromyelitis optica spectrum disorder; orbit; spine.
Similar articles
-
Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.Mult Scler. 2022 Jan;28(1):49-60. doi: 10.1177/13524585211007086. Epub 2021 Apr 19. Mult Scler. 2022. PMID: 33870786
-
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.Mult Scler. 2022 Feb;28(2):217-227. doi: 10.1177/13524585211018987. Epub 2021 May 28. Mult Scler. 2022. PMID: 34048323 Free PMC article.
-
Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS.J Neurol Sci. 2023 Jul 15;450:120687. doi: 10.1016/j.jns.2023.120687. Epub 2023 May 12. J Neurol Sci. 2023. PMID: 37201267 Free PMC article.
-
MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.J Neuroimaging. 2023 Sep-Oct;33(5):688-702. doi: 10.1111/jon.13137. Epub 2023 Jun 15. J Neuroimaging. 2023. PMID: 37322542 Review.
-
Clinical and neuroimaging findings in MOGAD-MRI and OCT.Clin Exp Immunol. 2021 Dec;206(3):266-281. doi: 10.1111/cei.13641. Epub 2021 Jul 18. Clin Exp Immunol. 2021. PMID: 34152000 Free PMC article. Review.
Cited by
-
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review.J Cent Nerv Syst Dis. 2023 Mar 29;15:11795735231167869. doi: 10.1177/11795735231167869. eCollection 2023. J Cent Nerv Syst Dis. 2023. PMID: 37008248 Free PMC article. Review.
-
Clinical, Lab, and Radiological Evolution of an Adult Patient With Unilateral Cortical Lesion in Anti-Myelin Oligodendrocyte Glycoprotein (MOG)-Associated Encephalitis With Seizures and Anti-Glial Fibrillary Acidic Protein (GFAP) Positive Antibodies.Cureus. 2024 Sep 30;16(9):e70546. doi: 10.7759/cureus.70546. eCollection 2024 Sep. Cureus. 2024. PMID: 39479094 Free PMC article.
-
Magnetic resonance imaging in neuromyelitis optica spectrum disorder.Clin Exp Immunol. 2021 Dec;206(3):251-265. doi: 10.1111/cei.13630. Epub 2021 Jul 6. Clin Exp Immunol. 2021. PMID: 34080180 Free PMC article. Review.
-
Glial cells and neurologic autoimmune disorders.Front Cell Neurosci. 2022 Oct 26;16:1028653. doi: 10.3389/fncel.2022.1028653. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36385950 Free PMC article. Review.
-
Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease.Mult Scler J Exp Transl Clin. 2022 Nov 15;8(4):20552173221131235. doi: 10.1177/20552173221131235. eCollection 2022 Oct-Dec. Mult Scler J Exp Transl Clin. 2022. PMID: 36407471 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical